Epidemiology of drug-induced liver injury
10.3969/j.issn.1001-5256.2021.11.002
- VernacularTitle:药物性肝损伤的流行病学
- Author:
Xiaoyun LI
1
;
Jieting TANG
1
Author Information
1. Shanghai Research Center for Diagnosis and Treatment of Fatty Liver Disease, Shanghai Institute of Digestive Disease, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200001, China
- Publication Type:Discussions by experts
- Keywords:
Chemical and Drug-Induced Liver Injury;
Epidemiologic Studies;
Retrospective Studies;
Prospective Studies
- From:
Journal of Clinical Hepatology
2021;37(11):2510-2514
- CountryChina
- Language:Chinese
-
Abstract:
The incidence rate of drug-induced liver injury (DILI) is increasing year by year, and DILI has become one of the common liver diseases in clinical practice and has attracted the attention of the whole world. It is known that a variety of drugs, including Chinese herbal medicine and dietary supplements, can cause various types of acute or chronic liver injury, and acute liver failure may occur in severe cases, leading to death or liver transplantation. This article elaborates on the global prevalence of DILI and the distribution of common suspected drugs.
